Dicerna Pharmaceuticals is a biotechnology company involved in the discovery and development of innovative treatments for rare inherited diseases affecting the liver, along with cancers, and other therapeutic areas to address liver problems. It is using ribonucleic acid interference (RNA) technology platform to develop its products. The product candidates are DCR-PHXC (for primary hyperoxaluria), DCR-undisclosed (for orphan genetic disease), DCR-PCSK9 (for cardiovascular disease), and DCR-HBV (for hepatitis B virus) among others. The company was founded in 2007 and is headquartered in Lexington, Massachusetts.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Dicerna Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Dicerna Pharmaceuticals Inc market cap is $2.98B.
What is the 52-week high for Dicerna Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Dicerna Pharmaceuticals Inc 52 week high is $40.14 as of September 09, 2025.
What is the 52-week low for Dicerna Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dicerna Pharmaceuticals Inc 52 week low is $19.06 as of September 09, 2025.
What is Dicerna Pharmaceuticals Inc stock price today?
Dicerna Pharmaceuticals Inc stock price today is $38.22.
What was Dicerna Pharmaceuticals Inc stock price yesterday?
Dicerna Pharmaceuticals Inc stock price yesterday was $38.00.
What is the PE ratio of Dicerna Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dicerna Pharmaceuticals Inc’s P/E ratio is -23.44.
What is the Price-to-Book ratio of Dicerna Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Dicerna Pharmaceuticals Inc P/B ratio is 27.6310.
What is the 50-day moving average of Dicerna Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Dicerna Pharmaceuticals Inc 50-day moving average is $30.42.
